A secret that hides Biocryst Pharmaceuticals Inc.’s strength (NASDAQ:BCRX)
Stocks of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 10.39% to $5.95. According to the data, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 12 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and […]
Does Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) warrant a purchase right now? What to Consider Before Making a Decision
Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) shares traded 2.90% higher at $5.67 on Wall Street last session. In accordance with the data, 12 analysts cover Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and a low of $6.00, […]
Before You Invest In Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX), Consider This Metric
Stocks of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, down -1.57% to $5.64. According to the data, Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 11 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and […]
How should investors evaluate BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)?
Stocks of BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 7.34% to $7.60. BCRX stock price is now 0.08% away from the 50-day moving average and -20.41% away from the 200-day moving average. The market capitalization of the company currently stands at $1.34B. With the price target maintained at $11, Jefferies […]
BioCryst Pharmaceuticals Inc. (BCRX) – Mismatched value: Check Out the Fundamental Analysis
Stocks of BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) traded higher last session on Wall Street, up 3.66% to $7.92. According to the data, BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) has 11 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $30.00 and […]
The shares of BioCryst Pharmaceuticals Inc. (BCRX) have recorded the market capitalization of 1.36B
The stock of BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) last traded at $7.04, up 1.15% from the previous session. Data from the available sources indicates that BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is covered by 11 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]